Blue Ocean Clinical Research

Clearwater, Florida 33761-2046

0 studies enrolling now · 8 studies all time

What they study most

Diabetes Mellitus, Diabetic Macular Edema, Diabetic Retinopathy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Panuveitis, Uveitis, Intermediate, Uveitis, Posterior, Wet Age Related Macular Degeneration, Wet Age-related Macular Degeneration, wAMD

Studies at this site

• A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema — Running, not enrolling
• A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) — Completed
• A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK — Running, not enrolling
• A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) — Stopped early
• A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema — Completed
• Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) — Stopped early